MX2011007817A - Formulacion farmaceutica o alimenticia de liberacion controlada y proceso para su preparacion. - Google Patents

Formulacion farmaceutica o alimenticia de liberacion controlada y proceso para su preparacion.

Info

Publication number
MX2011007817A
MX2011007817A MX2011007817A MX2011007817A MX2011007817A MX 2011007817 A MX2011007817 A MX 2011007817A MX 2011007817 A MX2011007817 A MX 2011007817A MX 2011007817 A MX2011007817 A MX 2011007817A MX 2011007817 A MX2011007817 A MX 2011007817A
Authority
MX
Mexico
Prior art keywords
preparation
release pharmaceutical
controlled release
food formulation
food
Prior art date
Application number
MX2011007817A
Other languages
English (en)
Inventor
Leonardo Marchitto
Lorella Ragni
Vincenzo Russo
Giovanni Battista Ciottoli
Elisa Liberati
Stefano Selva
Original Assignee
A F S P A Aziende Chimichi Riunite Angelini Francesco A C R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A F S P A Aziende Chimichi Riunite Angelini Francesco A C R filed Critical A F S P A Aziende Chimichi Riunite Angelini Francesco A C R
Publication of MX2011007817A publication Critical patent/MX2011007817A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734—Alginic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

La presente invención se refiere a una formulación farmacéutica o alimenticia de liberación controlada que comprende al menos un ingrediente farmacéutico o alimenticio activo disperso en una mezcla de glucógeno con un polisacárido, y el proceso para su preparación. La invención se refiere también a un sistema de liberación lenta representado por una mezcla de un glucógeno con un polisacárido, y su uso para la preparación de formulaciones farmacéuticas o alimenticias de liberación lenta.
MX2011007817A 2009-01-23 2010-01-08 Formulacion farmaceutica o alimenticia de liberacion controlada y proceso para su preparacion. MX2011007817A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09425014 2009-01-23
PCT/EP2010/050137 WO2010084038A1 (en) 2009-01-23 2010-01-08 Controlled release pharmaceutical or food formulation and process for its preparation

Publications (1)

Publication Number Publication Date
MX2011007817A true MX2011007817A (es) 2011-09-21

Family

ID=40886215

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011007817A MX2011007817A (es) 2009-01-23 2010-01-08 Formulacion farmaceutica o alimenticia de liberacion controlada y proceso para su preparacion.

Country Status (16)

Country Link
US (1) US9125823B2 (es)
EP (1) EP2389163B1 (es)
JP (2) JP5723787B2 (es)
KR (1) KR101713810B1 (es)
CN (1) CN102271664B (es)
AR (1) AR075039A1 (es)
AU (1) AU2010206221B2 (es)
BR (1) BRPI1006902A2 (es)
CA (1) CA2745737C (es)
EA (1) EA026651B1 (es)
GE (1) GEP20146013B (es)
IL (1) IL213190A (es)
MX (1) MX2011007817A (es)
SG (2) SG171444A1 (es)
UA (1) UA104159C2 (es)
WO (1) WO2010084038A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1993559B1 (en) 2006-02-03 2016-06-22 OPKO Renal, LLC Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
PT3357496T (pt) 2006-06-21 2020-05-12 Opko Ireland Global Holdings Ltd Terapia utilizando um agente de repleção de vitamina d e um agente de substituição hormonal de vitamina d
WO2008134512A1 (en) 2007-04-25 2008-11-06 Cytochroma Inc. Oral controlled release compositions comprising vitamin d compound and waxy carrier
DK2148684T3 (da) 2007-04-25 2013-04-22 Cytochroma Inc Fremgangsmåde til behandling af vitamin D-insufficiens og -deficiens
EP2389163B1 (en) * 2009-01-23 2021-09-01 AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO - A.C.R.A.F. - S.p.A. Controlled release pharmaceutical or food formulation and process for its preparation
BR112012002350B1 (pt) * 2009-08-03 2018-07-03 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Formulação alimentar artificial para a liberação controlada de glicose, e, uso de glicogênio
EP2552484B1 (en) 2010-03-29 2020-01-08 Opko Ireland Global Holdings, Ltd. Methods and compositions for reducing parathyroid levels
CA2806619C (en) * 2010-05-24 2018-05-22 Ozstar Therapeutics Pty Ltd Anti-diabetic compositions and methods
US9132291B2 (en) 2010-10-05 2015-09-15 Dfb Technology, Ltd. Water-in-oil emulsion compositions containing gellan gum for topical delivery of active ingredients to the skin or mucosa
CN105193809B (zh) 2010-10-15 2019-07-16 康特拉医药公司 用于治疗运动障碍的血清素受体激动剂组合物
US10561618B2 (en) 2012-04-18 2020-02-18 Contera Pharma Aps Orally available pharmaceutical formulation suitable for improved management of movement disorders
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
CN103478732B (zh) * 2013-09-30 2015-08-19 杭州拜善晟生物科技有限公司 一种骨架缓释维生素功能型食品及其制备方法
WO2016020508A2 (en) 2014-08-07 2016-02-11 Opko Ireland Global Holdings Ltd. Adjunctive therapy with 25-hydroxyvitamin d
US11173168B2 (en) 2016-03-28 2021-11-16 Eirgen Pharma Ltd. Methods of treating vitamin D insufficiency in chronic kidney disease
EP3481385A1 (en) 2016-07-11 2019-05-15 Contera Pharma APS Pulsatile drug delivery system for treating morning akinesia
EA202090748A1 (ru) * 2017-06-16 2020-08-11 Борис Славинович ФАРБЕР Биологически активные комбинаторные производные полисахаридов

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3493652A (en) * 1962-09-14 1970-02-03 Charles W Hartman Controlled release medicament
JPS62178505A (ja) 1986-02-03 1987-08-05 Maruzen Kasei Kk 化粧料
JPS63290809A (ja) 1987-05-25 1988-11-28 Noebia:Kk ***用化粧料
US4983398A (en) * 1987-12-21 1991-01-08 Forest Laboratories, Inc. Sustained release drug dosage forms containing hydroxypropylmethylcellulose and alkali metal carboxylates
CA2041774C (en) 1990-11-27 1994-04-19 Mircea A. Mateescu Use of cross-linked amylose as a matrix for the slow release of biologically active compounds
IT1255488B (it) * 1992-08-04 1995-11-06 Angelini Francesco Ist Ricerca Polisaccaridi del glicogeno
US5393765A (en) 1993-12-13 1995-02-28 Hoffmann-La Roche Inc. Pharmaceutical compositions with constant erosion volume for zero order controlled release
US5807575A (en) 1997-02-14 1998-09-15 Rougier Inc. Manufacture of cross-linked amylose useful as a excipient for control release of active compounds
US20060127387A1 (en) 1997-04-22 2006-06-15 Zikria Bashir A Compositions based on polysaccharides and protein C and methods of using the same for preventing and treating sepsis and other conditions
US20060264357A1 (en) 1997-04-22 2006-11-23 Zikria Bashir A Capillary membrane stabilization and reduction of tissue injury through use of biodegradable macromolecules with antioxidants and/or other chemicals
EP1072269B1 (en) 1997-11-24 2005-10-12 Zhongming Zeng Use of dextrin, starch or glycogen for the treatment of bacterial vaginosis
IT1298758B1 (it) 1998-03-19 2000-02-02 Angelini Ricerche Spa Soluzione umettante e lubrificante per uso oftalmico
CZ300551B6 (cs) 1999-03-31 2009-06-17 Janssen Pharmaceutica N. V. Predželatinovaný škrob v rízene se uvolnující formulaci
US6607748B1 (en) 2000-06-29 2003-08-19 Vincent Lenaerts Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
SE528337C2 (sv) 2004-06-23 2006-10-24 Nestor Medical Ab Sammansättning innefattande mjölksyra och laktoferrin, eller ett peptidfragment därav, och användning av denna sammansättning för behandling av tillstånd i urogenitalsystemet
ITMI20042356A1 (it) * 2004-12-10 2005-03-10 Acraf Composizione farmaceutica orodisperdibile e procedimento per prepararla
US8461130B2 (en) * 2006-12-28 2013-06-11 Ezaki Glico Co., Ltd. Food containing glycogen and use thereof
UA98684C2 (uk) 2007-12-28 2012-06-11 Ацьенде Кимике Риуните Анджелини Франческо А.Чи.Р.А.Ф. С.П.А. Композиція повільного вивільнення на основі асоціації глікогену та альгінату
EP2389163B1 (en) * 2009-01-23 2021-09-01 AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO - A.C.R.A.F. - S.p.A. Controlled release pharmaceutical or food formulation and process for its preparation

Also Published As

Publication number Publication date
SG171444A1 (en) 2011-07-28
KR20110116006A (ko) 2011-10-24
WO2010084038A1 (en) 2010-07-29
JP2012515738A (ja) 2012-07-12
IL213190A (en) 2016-03-31
US20110318321A1 (en) 2011-12-29
EP2389163A1 (en) 2011-11-30
CN102271664B (zh) 2013-11-20
BRPI1006902A2 (pt) 2016-02-16
AU2010206221B2 (en) 2016-07-14
EA201170954A1 (ru) 2011-12-30
KR101713810B1 (ko) 2017-03-09
UA104159C2 (uk) 2014-01-10
US9125823B2 (en) 2015-09-08
GEP20146013B (en) 2014-01-27
JP2015129132A (ja) 2015-07-16
CA2745737A1 (en) 2010-07-29
AR075039A1 (es) 2011-03-02
CA2745737C (en) 2018-05-01
JP5723787B2 (ja) 2015-05-27
SG196810A1 (en) 2014-02-13
AU2010206221A1 (en) 2010-07-29
EP2389163B1 (en) 2021-09-01
IL213190A0 (en) 2011-07-31
JP5934812B2 (ja) 2016-06-15
EA026651B1 (ru) 2017-05-31
CN102271664A (zh) 2011-12-07

Similar Documents

Publication Publication Date Title
MX2011007817A (es) Formulacion farmaceutica o alimenticia de liberacion controlada y proceso para su preparacion.
PH12014502778B1 (en) Antibody formulation
MX348823B (es) Formulaciones estables de linaclotida.
WO2012078593A3 (en) Lysophosphatidic acid receptor antagonists and their use in the treatment fibrosis
MX2014011815A (es) Composiciones farmaceuticas de liberacion inmediata con propiedades disuasivas de abuso.
WO2011041462A3 (en) Polycyclic compounds as lysophosphatidic acid receptor antagonists
MX356111B (es) Composiciones farmaceuticas disuasorias de abuso, de liberacion inmediata.
WO2010000877A3 (en) Formulation with irritation reducing action comprising bisabolol and [6]-paradol
TN2012000566A1 (en) Dry powder formulation comprising an antimuscarinic drug
SG10201804817TA (en) Delayed release compositions of linaclotide
WO2010021607A3 (en) Pharmaceutical formulation
JO3122B1 (ar) مشتقات إسترا-5،3،1(10)، 16- تترايين-3- كربوكساميد، عمليات لتحضيرها، مستحضرات دوائية تشتمل عليها واستخدامها لتحضير أدوية
EP3878445A3 (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
TN2012000488A1 (en) Pharmaceutical compositions comprising hydromorphone and naloxone
MX2016001422A (es) Composicion farmaceutica de fingolimod.
WO2011002422A3 (en) Solubility enhancing pharmaceutical formulation
PH12015501377A1 (en) Solid unit with high fexofenadine content and process for the preparation thereof
WO2013170086A3 (en) Formulations for the delivery of active ingredients
WO2011139249A3 (en) Pharmaceutical composition comprising cefdinir
AU2012345659A8 (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
IN2012CH05549A (es)
WO2010109115A9 (fr) Composés anticancéreux, leur préparation et leur application en thérapeutique
WO2013127539A3 (de) Pharmazeutische formulierung enthaltend flupirtin
MX2011011879A (es) Uso de las betaxantinas y sus derivados para preparar un medicamento para el tratamiento de la prediabetes y diabetes.
MY194591A (en) Pharmaceutical combination formulation

Legal Events

Date Code Title Description
FG Grant or registration